We are excited to announce the successful first closing of our A2 financing round!
This will allow us to accelerate our developments towards a full product suite that will help to better serve patients, sites, sponsors and regulatory agencies.
We are grateful to have the support of a strong group of investors who share PharmaTrail’s vision and the potential of blockchain as the new standard for ensuring data security, integrity, and transparancy in clinical trials.
Our eConsent pilot study has concluded successfully! We would like to express our sincere gratitude to the clinical trial sites and participants for the time and dedication in testing as well as our partner BioValeo for all their support. Their valuable feedback will be instrumental in helping us improve our software and provide the best user experience possible!
We are thrilled to announce that our eConsent pilot study has been started successfully together with our partner BioValeo. Our blockchain-based platform is now working under real-life conditions!
We are happy to announce that our team is growing with two highly talented new members.
Damian Schraube joined the PharmaTrail team as Head of Product Management. Damian brings with him >15 years of experience in clinical trials and clinical trial IT systems both within CROs and Pharma companies. With his unique expertise we are convinced that Damian will help PharmaTrail to develop software that will be real assets to our customers. We are excited to have Damian on the PharmaTrail team.
Jonas Placzek has joined the PharmaTrail team as Junior Product Manager. Jonas did his Bachelor in medical computer science and his thesis with PharmaTrail last year. As a passionist about UI/UX we are looking forward to his contribution to PharmaTrail’s Clinical Trial Suite and are convinced that he will enable PharmaTrail to provide superior solutions to our customers.